Patents Assigned to Bristol-Myers Squibb Pharme Company
  • Lactam metalloprotease inhibitors
    Patent number: 6620823
    Abstract: The present application describes novel lactams and derivatives thereof of formula I: or pharmaceutically acceptable salt forms thereof, wherein ring B is a 4-8 membered cyclic amide comprising 0-3 additional heteroatoms selected from N, O, and S, which are useful as metalloprotease inhibitors.
    Type: Grant
    Filed: July 10, 2001
    Date of Patent: September 16, 2003
    Assignee: Bristol-Myers Squibb Pharme Company
    Inventors: Thomas P Maduskuie, Jingwu Duan, Stephen E Mercer